Pei-Jer Chen

31PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineCardiology (incl. cardiovascular diseases)Haematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jan 20, 2026
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease.

Yu-Ping Chang, Yun-Chu Chen, Pin-Nan Cheng

|Nov 14, 2025
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Yun-Chu Chen, Yu-Ping Chang, Ji-Yuh Lee

|Jun 20, 2025
Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold.

Tai-Chung Tseng, Shang-Chin Huang, Mei-Hung Pan

|Apr 05, 2025
Sequential combination with ropeginterferon alfa-2b and anti-PD-1 treatment as adjuvant therapy in HBV-related HCC: a phase 1 dose escalation trial.

Albert Qin, Ming-Chih Ho, Chan-Yen Tsai

|Jan 01, 2025
HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC.

Chiao-Ling Li, Chia-Lang Hsu, You-Yu Lin

|Sep 06, 2024
Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease.

Feng-Pai Tsai, Tung-Hung Su, Shang-Chin Huang

Pageof 6

Frequent Collaborators

11 joint publications

Jia-Horng Kao

8 joint publications

Tung-Hung Su

7 joint publications

Chen-Hua Liu

6 joint publications

Chun-Jen Liu